Discover 3,553 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,553
Active & Responsive
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
for
Volume Loss (Soft Tissue Ptosis or Atrophy )
Location: Pasadena CA
Sponsor: Kalpna Kay Durairaj, MD, FACS
Sex: All
Age: 21 - 65
Code: NCT07419854
Recruiting
Active & ResponsiveNew
Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy
for
Androgenic Alopecia, Female Pattern Hair Loss, Hair Loss
Location: Pasadena CA
Sponsor: K. Kay Durairaj, MD, FACS, A Medical Corporation
Sex: Female
Age: 35 - 55
Code: NCT07810504
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Los Angeles CA, Long Beach CA, Pomona CA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase3, Recruiting
Active & Responsive
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
for
Venous Leg Ulcer (VLU)
Location: Los Angeles CA, Vista CA, Fresno CA, San Francisco CA,
Sponsor: MediWound Ltd
Sex: All
Age: 18+
Code: NCT06568627
Phase3, Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Los Angeles CA, Montebello CA, Lakewood CO, Bellevue WA,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
for
Ductal Carcinoma in Situ
Location: South Pasadena CA, Los Angeles CA, Duarte CA, Irvine CA,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: Female
Age: 18+
Code: NCT06075953
Phase2, Recruiting
Active & Responsive
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: South Pasadena CA, Arcadia CA, Duarte CA,
Sponsor: City of Hope Medical Center
Sex: Female
Age: 18+
Code: NCT07741968
Recruiting
Active & Responsive
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
for
Graves' Disease, Graves Disease
Location: Pasadena CA, Orange CA, Shavano Park TX, Irving TX,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07570316
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Los Angeles CA, Pasadena CA, Inglewood CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Los Angeles CA, Pasadena CA, Tarzana CA, Long Beach CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
for
ADHD
Location: Los Angeles CA, Long Beach CA, Irvine CA, Las Vegas NV,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 12 - 17
Code: NCT07717892
Phase3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Los Angeles CA, Rancho Mirage CA, Las Vegas NV,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Los Angeles CA, Beverly Hills CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase2, Recruiting
Active & ResponsiveNew
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Los Angeles CA, Beverly Hills CA, Topeka KS,
Location: Los Angeles CA, Beverly Hills CA, Palo Alto CA,
Sponsor: Pheast Therapeutics
Sex: All
Age: 18+
Code: NCT06840886
Phase1, Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Los Angeles CA, Fullerton CA, Long Beach CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase3, Recruiting
Active & Responsive
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
for
Unresectable or Metastatic Hepatocellular Carcinoma,
Location: Los Angeles CA, Peoria IL, Atlanta GA
Sponsor: CatalYm GmbH
Sex: All
Age: 18 - 70+
Code: NCT07219459
Phase2, Recruiting
Active & Responsive
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
for
Lung Non-Small Cell Carcinoma
Location: Los Angeles CA, Bismarck ND, Sioux Falls SD, Fargo ND,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07293247
Phase2, Recruiting
Active & Responsive
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
for
Advanced Solid Tumors, Metastatic Solid Tumors,
Location: Los Angeles CA, San Antonio TX, Irving TX, Houston TX,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07397338
Phase1, Phase2, Recruiting
Active & Responsive
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma